journal article·2025-11-12Open access

Chitosan/Alginate Polyelectrolyte Magnetic Gel Nanoarchitectonics with Tunable Mechanical Properties for Magnetic Hyperthermia and Sustained Release of 5-Fluorouracil

Sérgio R. S. Veloso, Margarita Vázquez-González, Mariana O. Ribeiro, Loic Hilliou, Carlos O. Amorim, Vítor S. Amaral, Miguel A. Correa-Duarte, Elisabete M. S. Castanheira

ACS Applied Materials & Interfaces· Volume 17· Issue 45

Abstract

High Resolution Image Download MS PowerPoint Slide Chitosan-based hydrogels hold promise as drug delivery systems for cancer therapy, but the poor mechanical properties often limit the biological application, requiring chemical cross-linking to improve sustained drug release. Besides, the addition of stimulus-responsiveness to chitosan requires chemical modifications that can further affect the gel properties. To overcome these challenges, in this work, a novel chitosan/alginate polyelectrolyte magnetic gel with tunable mechanical properties is developed by pH-triggered self-assembly. The gels could be prepared by a slow/fast pH decrease and blended with magnetic nanoparticles. Manganese-doped ferrite nanoparticles (∼10 nm) with suitable magnetic properties (>70 Am 2 /kg) and high magnetic hyperthermia heating efficiency (ILP > 3 nHm 2 /kg) were synthesized via an amino acid-assisted oxidative hydrothermal method. The nanoparticles and self-assembly conditions of the polyelectrolyte complex enabled the tuning of the gels’ properties, a fast gelation, and suitable mechanical properties for drug delivery. Notably, gels with a large storage modulus (up to 10 kPa) could be prepared at a low polymer concentration (≤2 wt %). The magnetic gels enabled the sustained release of a hydrophilic chemotherapeutic drug model, 5-fluorouracil (5-FU), under mimetic physiological conditions, outperforming the hydrogels. Moreover, the drug release kinetics was synergistically enhanced under the combined effect of acidic conditions and magnetic hyperthermia. Hence, the developed self-assembled chitosan/alginate magnetic gel showed promising multifunctionality, combining tunable mechanical properties, magnetic hyperthermia capability, and sustained drug release. These features highlight the self-assembled chitosan/alginate magnetic gels as promising and versatile materials for localized and controlled drug delivery.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Hydrogels: synthesis, properties, applications · Nanoparticle-Based Drug Delivery · Polymer Surface Interaction Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Physics Centre of Minho and Porto Universities (CF-UM-UP), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal

LaPMET Associate Laboratory, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal

Centro de Investigación en Nanomateriais e Biomedicina (CINBIO)

Universidad de Vigo

Institute for Polymers and Composites, Department of Polymer Engineering, University of Minho, Campus de Azurém, Guimarães, 4800-058, Portugal

Physics Department and i3N, University of Aveiro, Campus de Santiago, Aveiro 3810-193, Portugal

Physics Department and CICECO, University of Aveiro, Campus de Santiago, Aveiro 3810-193, Portugal

Funding

HORIZON EUROPE European Innovation Council · Agencia Estatal de Investigaci?n · Xunta de Galicia · NextGenerationEU · Funda??o para a Ci?ncia e a Tecnologia

References (70)

Show source-provided references
1. 10.1039/b925138c10.1039/b925138c ↗
2. 10.1016/j.polymer.2023.12624210.1016/j.polymer.2023.126242 ↗
3. 10.3390/md1611041610.3390/md16110416 ↗
4. 10.1016/j.ijbiomac.2018.12.19510.1016/j.ijbiomac.2018.12.195 ↗
5. 10.1016/j.jconrel.2020.06.01210.1016/j.jconrel.2020.06.012 ↗
6. 10.1039/C6QM00002A10.1039/C6QM00002A ↗
7. 10.1016/j.colsurfb.2018.05.00210.1016/j.colsurfb.2018.05.002 ↗
8. 10.1016/j.carbpol.2008.04.04810.1016/j.carbpol.2008.04.048 ↗
9. 10.3390/pharmaceutics1003014510.3390/pharmaceutics10030145 ↗
10. 10.1016/j.cis.2020.10235110.1016/j.cis.2020.102351 ↗
11. 10.3390/ijms2401018610.3390/ijms24010186 ↗
12. 10.1016/j.ijbiomac.2023.12572210.1016/j.ijbiomac.2023.125722 ↗
13. 10.1002/adfm.20240292610.1002/adfm.202402926 ↗
14. 10.1016/j.msec.2019.04.01210.1016/j.msec.2019.04.012 ↗
15. 10.1016/j.mtcomm.2024.10882210.1016/j.mtcomm.2024.108822 ↗
16. 10.1016/j.jiec.2021.07.04310.1016/j.jiec.2021.07.043 ↗
17. 10.1016/j.ijbiomac.2019.04.00510.1016/j.ijbiomac.2019.04.005 ↗
18. 10.1016/j.ijbiomac.2020.09.07210.1016/j.ijbiomac.2020.09.072 ↗
19. 10.1016/j.ijbiomac.2021.01.06710.1016/j.ijbiomac.2021.01.067 ↗
20. 10.1177/0963689722112608810.1177/09636897221126088 ↗
21. 10.1016/j.carbpol.2015.04.02210.1016/j.carbpol.2015.04.022 ↗
22. 10.1038/nrc107410.1038/nrc1074 ↗
23. 10.1016/j.pharmthera.2019.10744710.1016/j.pharmthera.2019.107447 ↗
24. 10.2147/IJN.S25770010.2147/IJN.S257700 ↗
25. 10.1016/j.ijpharm.2011.04.05210.1016/j.ijpharm.2011.04.052 ↗
26. 10.1021/acs.jpcc.5b0719510.1021/acs.jpcc.5b07195 ↗
27. 10.1016/j.vibspec.2023.10354010.1016/j.vibspec.2023.103540 ↗
28. 10.1515/chem-2021-007710.1515/chem-2021-0077 ↗
29. 10.1021/jp075449u10.1021/jp075449u ↗
30. 10.1016/j.apcata.2009.05.03010.1016/j.apcata.2009.05.030 ↗
31. 10.1021/acs.chemmater.2c0156810.1021/acs.chemmater.2c01568 ↗
32. 10.1016/j.ccr.2022.21480910.1016/j.ccr.2022.214809 ↗
33. 10.1016/j.colsurfa.2022.12909010.1016/j.colsurfa.2022.129090 ↗
34. 10.1016/j.jallcom.2020.15798310.1016/j.jallcom.2020.157983 ↗
35. 10.3390/nano501006310.3390/nano5010063 ↗
36. 10.1016/j.matdes.2016.09.03110.1016/j.matdes.2016.09.031 ↗
37. 10.3390/pharmaceutics1412269410.3390/pharmaceutics14122694 ↗
38. 10.3390/ijms23221414510.3390/ijms232214145 ↗
39. 10.1039/D1RA02376D10.1039/D1RA02376D ↗
40. 10.1021/acsomega.2c0565110.1021/acsomega.2c05651 ↗
41. 10.1088/1748-605X/ac2b7a10.1088/1748-605X/ac2b7a ↗
42. 10.1016/j.ijbiomac.2024.12985810.1016/j.ijbiomac.2024.129858 ↗
43. 10.1016/j.ijbiomac.2024.13122010.1016/j.ijbiomac.2024.131220 ↗
44. 10.1016/j.eurpolymj.2019.08.00910.1016/j.eurpolymj.2019.08.009 ↗
45. 10.1016/j.coco.2022.10134410.1016/j.coco.2022.101344 ↗
46. 10.1016/j.progpolymsci.2011.02.00210.1016/j.progpolymsci.2011.02.002 ↗
47. 10.3390/gels1008050710.3390/gels10080507 ↗
48. 10.1039/C9SM00709A10.1039/C9SM00709A ↗
49. 10.1021/acs.biomac.4c0124010.1021/acs.biomac.4c01240 ↗
50. 10.1039/D1NR08158F10.1039/D1NR08158F ↗
51. 10.3390/nano1101001610.3390/nano11010016 ↗
52. 10.3311/PPch.1714810.3311/PPch.17148 ↗
53. 10.1016/j.colsurfa.2023.13273910.1016/j.colsurfa.2023.132739 ↗
54. 10.1016/j.eurpolymj.2021.11064410.1016/j.eurpolymj.2021.110644 ↗
55. 10.1039/D2NR05073K10.1039/D2NR05073K ↗
56. 10.1016/j.jmmm.2018.09.11310.1016/j.jmmm.2018.09.113 ↗
57. 10.3390/nano910145710.3390/nano9101457 ↗
58. 10.1016/j.semcancer.2017.03.00110.1016/j.semcancer.2017.03.001 ↗
59. 10.1039/C8RA02095G10.1039/C8RA02095G ↗
60. 10.1016/j.ijbiomac.2023.12889510.1016/j.ijbiomac.2023.128895 ↗
61. 10.1016/j.jddst.2019.03.03610.1016/j.jddst.2019.03.036 ↗
62. 10.1016/j.jiec.2017.08.02410.1016/j.jiec.2017.08.024 ↗
63. Eldin M. S. M. M. O. · Int. J. Pharm. Pharm. Sci. · 2015 · 7 · 331
64. 10.1016/j.ijbiomac.2019.03.22510.1016/j.ijbiomac.2019.03.225 ↗
65. 10.1016/j.clay.2014.09.00410.1016/j.clay.2014.09.004 ↗
66. Dash S. · Acta Polym. Pharm. - Drug Res. · 2010 · 67 · 217
67. 10.1016/0168-3659(87)90035-610.1016/0168-3659(87)90035-6 ↗
68. 10.1088/0957-4484/26/36/36510310.1088/0957-4484/26/36/365103 ↗
69. 10.1088/1361-6501/ac0d2310.1088/1361-6501/ac0d23 ↗
70. 10.3390/gels807041210.3390/gels8070412 ↗